These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16048564)

  • 1. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
    Loria P; Lonardo A; Lombardini S; Carulli L; Verrone A; Ganazzi D; Rudilosso A; D'Amico R; Bertolotti M; Carulli N
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
    Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
    Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.
    Radu C; Grigorescu M; Crisan D; Lupsor M; Constantin D; Dina L
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):255-60. PubMed ID: 18836616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.
    Jimba S; Nakagami T; Takahashi M; Wakamatsu T; Hirota Y; Iwamoto Y; Wasada T
    Diabet Med; 2005 Sep; 22(9):1141-5. PubMed ID: 16108839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
    Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
    Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
    Lu H; Zeng L; Liang B; Shu X; Xie D
    Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].
    Zhou WD; Yang YL; Che ZH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):565-70. PubMed ID: 18667766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
    Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
    Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
    Shieh K; Gilchrist JM; Promrat K
    Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.
    Lee JY; Kim KM; Lee SG; Yu E; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Hepatol; 2007 Aug; 47(2):239-44. PubMed ID: 17400323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
    Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.